NURTEC® ODT achieved preliminary net product revenue of approximately $93 million for the second quarter of 2021 Launch to date net product revenue for NURTEC ODT is approximately $200 million with over 750,000 prescriptions filled since initial product launch in March 2020, and NURTEC ODT now accounts for […]

Kurt Merkelz, M.D. More prescriptions do not necessarily mean better health outcomes. Deprescribing, which is the planned and supervised process of intentionally stopping a medication or reducing its dose, is a critically important part of delivering safe, effective, patient-centered care, especially for older adults.  I commend AMDA — the Society […]